Hopewell Pharma Ventures, Inc. et al. vs. Merck Serono SA
Explore the PTAB proceeding IPR2023-00481 filed by Hopewell Pharma Ventures, Inc. et al. on 2023-01-23. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-00481
Filing Date
2023-01-23
Accorded Filing Date
2023-01-23
Institution Decision Date
2023-09-22
Last Modified Date
2026-09-23
Proceeding Type
IPR
Termination Date
2024-09-18
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Hopewell Pharma Ventures, Inc. et al.
Represented By
Ellison, Eldoraet alPatent Owner / Respondent
Merck Serono SA
Represented By
Whelan, Emilyet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34305 | Richard Chinn | +1 571-458-7785 |
| 34429 | Paul Serbinowski | +1 571-389-8220 |
| 35020 | David Woodward | +1 703-328-7939 |
| 39318 | Samuel Ntiros | +1 703-207-0008 |
| 43224 | Carlos Villamar | +1 703-623-4122 |
| 47297 | Kirsten Grueneberg | +1 571-458-7783 |
| 81580 | Jaskiranjit Kang | +1 571-458-7793 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,377,903 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 63,866,904 P | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 4,106,909 | European Counterpart (EP) | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2006067141 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 72,201,807 A | US Continuation / Sibling | View Official Patent → |
TWi Pharmaceuticals, Inc. v. Merck Serono SA